|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
36.720 -0.100 (-0.272%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 6,738,246 | 3,862,355 | 3,116,468 | 2,741,205 |
| Net Cash from / (used in) Investing Activities | -- | (7,154,568) | (1,391,792) | 1,073,972 | (5,935,073) |
| Net Cash from / (used in) Financing Activities | -- | 1,554,120 | (6,065,945) | (753,695) | (818,144) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 1,137,798 | (3,595,382) | 3,436,745 | (4,012,012) |
| Cash & Cash Equivalents at beginning of period | -- | 2,322,701 | 5,980,513 | 2,666,132 | 6,718,709 |
| Effect of Foreign Exchange Rate Changes | -- | (51,580) | (62,430) | (122,364) | (40,565) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 3,408,919 | 2,322,701 | 5,980,513 | 2,666,132 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,257,941 |
| %Change | 35.823% |
| EPS / (LPS) | RMB 0.700 |
| NBV Per Share (¥) | RMB 6.228 |